Hepatic inactivation of murine


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
04 Oct 2022
Historique:
received: 09 08 2022
accepted: 03 10 2022
pubmed: 5 10 2022
medline: 22 10 2022
entrez: 4 10 2022
Statut: epublish

Résumé

PCSK9 negatively regulates low-density lipoprotein receptor (LDLR) abundance on the cell surface, leading to decreased hepatic clearance of LDL particles and increased levels of plasma cholesterol. We previously identified SURF4 as a cargo receptor that facilitates PCSK9 secretion in HEK293T cells (Emmer et al., 2018). Here, we generated hepatic SURF4-deficient mice (

Identifiants

pubmed: 36193893
doi: 10.7554/eLife.82269
pii: 82269
pmc: PMC9581532
doi:
pii:

Substances chimiques

PCSK9 protein, human EC 3.4.21.-
Proprotein Convertase 9 EC 3.4.21.-
RNA, Small Interfering 0
Receptors, LDL 0
Apolipoproteins B 0
Lipoproteins 0
Triglycerides 0
Cholesterol 97C5T2UQ7J
Lipoproteins, LDL 0
SURF4 protein, human 0
Membrane Proteins 0
Surf4 protein, mouse 0

Banques de données

GEO
['GSE214393']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R35 HL135793
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL148552
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL157062
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148333
Pays : United States

Informations de copyright

© 2022, Tang et al.

Déclaration de conflit d'intérêts

VT, JM, BX, YW, HF, XW, DS, RK, BE, XC, DG No competing interests declared

Références

Cell Metab. 2021 Feb 2;33(2):350-366.e7
pubmed: 33186557
J Lipid Res. 2021;62:100091
pubmed: 34118252
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5374-9
pubmed: 15805190
Eur Heart J. 2011 Jun;32(11):1345-61
pubmed: 21531743
J Biol Chem. 2004 Nov 19;279(47):48865-75
pubmed: 15358785
Elife. 2014 Oct 23;3:
pubmed: 25339419
PLoS Comput Biol. 2018 Aug 17;14(8):e1006360
pubmed: 30118475
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2202080119
pubmed: 35901214
Cell. 2004 Jan 23;116(2):153-66
pubmed: 14744428
Curr Protoc Protein Sci. 2010 Nov;Chapter 12:Unit12.4
pubmed: 21104982
Science. 1975 Aug 1;189(4200):347-58
pubmed: 1096303
Nature. 2021 May;593(7859):429-434
pubmed: 34012082
Science. 2001 Nov 16;294(5546):1528-31
pubmed: 11711675
Elife. 2022 Oct 04;11:
pubmed: 36193893
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158555
pubmed: 31676436
Nat Genet. 2005 Feb;37(2):161-5
pubmed: 15654334
J Cell Biol. 2018 Jun 4;217(6):2073-2085
pubmed: 29643117
Nature. 2017 May 18;545(7654):305-310
pubmed: 28489816
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell Biol. 2020 Nov 6;40(23):
pubmed: 32989016
EMBO J. 2002 Nov 15;21(22):6105-13
pubmed: 12426382
Nat Med. 2012 Oct;18(10):1539-49
pubmed: 22961109
J Cell Biol. 2006 Jan 30;172(3):383-93
pubmed: 16449189
Cell Mol Life Sci. 2018 Sep;75(18):3313-3327
pubmed: 29936596
PLoS Biol. 2018 Aug 7;16(8):e2005140
pubmed: 30086131
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Science. 2013 May 10;340(6133):689-90
pubmed: 23661745
Cardiovasc Ther. 2015 Apr;33(2):71-8
pubmed: 25604780
Front Cardiovasc Med. 2021 Nov 11;8:764024
pubmed: 34859075
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Oct;1867(10):159196
pubmed: 35803528
J Biol Chem. 2014 Jul 25;289(30):20858-70
pubmed: 24876386
Elife. 2018 Sep 25;7:
pubmed: 30251625
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Mol Biol Cell. 2008 May;19(5):1976-90
pubmed: 18287528
Annu Rev Genet. 2013;47:139-65
pubmed: 24274751
Atherosclerosis. 2007 Aug;193(2):445-8
pubmed: 16989838
EMBO Rep. 2007 Mar;8(3):258-64
pubmed: 17255961
Cell. 2014 Oct 9;159(2):440-55
pubmed: 25263330
Elife. 2013 Apr 09;2:e00444
pubmed: 23580231
Nat Rev Mol Cell Biol. 2020 Aug;21(8):421-438
pubmed: 32457508
PLoS One. 2020 Jan 24;15(1):e0227450
pubmed: 31978056
J Lipid Res. 2005 Sep;46(9):2023-8
pubmed: 15995182

Auteurs

Vi T Tang (VT)

Department of Molecular and Integrative Physiology, University of Michigan-Ann Arbor, Ann Arbor, United States.
Life Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.

Joseph McCormick (J)

Life Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.

Bolin Xu (B)

College of Future Technology, Peking University, Beijing, China.

Yawei Wang (Y)

Center for Life Sciences, Peking University, Beijing, China.

Huan Fang (H)

College of Future Technology, Peking University, Beijing, China.

Xiao Wang (X)

College of Future Technology, Peking University, Beijing, China.
State Key Laboratory of Membrane Biology, Peking University, Beijing, China.

David Siemieniak (D)

Life Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.
Howard Hughes Medical Institute, University of Michigan, Ann Arbor, United States.

Rami Khoriaty (R)

Department of Internal Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.
Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, United States.

Brian T Emmer (BT)

Department of Internal Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.

Xiao-Wei Chen (XW)

State Key Laboratory of Membrane Biology, Peking University, Beijing, China.

David Ginsburg (D)

Life Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.
Howard Hughes Medical Institute, University of Michigan, Ann Arbor, United States.
Department of Internal Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.
Department of Human Genetics, University of Michigan, Ann Arbor, United States.
Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH